Smith+Nephew $1 billion notes offering
Davis Polk advised Smith & Nephew plc in connection with the establishment of a WKSI shelf and its debut SEC-registered shelf takedown of $1 billion aggregate principal amount of 2.032%…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Fresnillo $850 million senior notes offering and concurrent tender offer
Davis Polk advised the initial purchasers in connection with the Rule 144A/Regulation S offering by Fresnillo plc of 4.250% senior notes due 2050 in the aggregate amount of $850…
Royalty Pharma $6 billion senior notes offering
Davis Polk advised Royalty Pharma plc in connection with its Rule 144A/Regulation S offering of $1 billion aggregate principal amount of its 0.75% senior notes due 2023, $1 billion…
Freeline Therapeutics Holdings $158.8 million IPO
Davis Polk advised Freeline Therapeutics Holdings plc on its $158.8 million initial public offering of 8,823,529 American depositary shares representing 8,823,529 ordinary shares, which…
Royalty Pharma $2.5 billion IPO
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…
Emirate of Abu Dhabi $3 billion notes reopening
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi of $1 billion aggregate principal amount of 2.500% notes due…
Emirate of Abu Dhabi $7 billion notes offering
Davis Polk advised the joint lead managers in connection with a Rule 144A/Regulation S offering by the Emirate of Abu Dhabi of $2 billion aggregate principal amount of 2.500% notes due 2025…
Davis Polk Advises Tencent on Its Investment in Sumo Group
Davis Polk is advising Tencent Holdings Limited in connection with its acquisition of a 9.96% shareholding in Sumo Group plc. The shares are being acquired from Sumo Group’s largest…
Oryzon Genomics’s Private Placement of Ordinary Shares
Davis Polk advised Oryzon Genomics, S.A. on its €20 million private placement of its ordinary shares pursuant to a capital increase. The offering consisted of a private placement to…
Zhenro Properties Group Limited $200 Million High-Yield Debt Offering
Davis Polk advised the initial purchasers in connection with a $200 million senior perpetual capital securities offering by Zhenro Properties Group Limited.
Zhenro Properties Group Limited…